Skip to main content

Coherus Oncology, Inc.

CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001512762

No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Coherus Oncology, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
−5 vs. Q2 2024
Shares held
76.9M
+6.15M (+8.7%) vs. Q2 2024
Total value
$79.9M
−$42.6M (−34.8%) vs. Q2 2024
New holders
17
41 more added
Sold out
22
32 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 128 institutions
Q1 2021: 205 institutionsQ2 2021: 188 institutionsQ3 2021: 188 institutionsQ4 2021: 201 institutionsQ1 2022: 184 institutionsQ2 2022: 176 institutionsQ3 2022: 174 institutionsQ4 2022: 161 institutionsQ1 2023: 163 institutionsQ2 2023: 161 institutionsQ3 2023: 169 institutionsQ4 2023: 156 institutionsQ1 2024: 137 institutionsQ2 2024: 135 institutionsQ3 2024: 128 institutionsQ4 2024: 124 institutionsQ1 2025: 117 institutionsQ2 2025: 112 institutionsQ3 2025: 114 institutionsQ4 2025: 128 institutionsQ1 2026: 158 institutionsQ2 2026: 146 institutions
Value heldQ3 2024: $79.9M
Q1 2021: $1.17BQ2 2021: $1.08BQ3 2021: $1.22BQ4 2021: $1.23BQ1 2022: $980.7MQ2 2022: $572.0MQ3 2022: $743.4MQ4 2022: $622.7MQ1 2023: $536.5MQ2 2023: $371.1MQ3 2023: $347.6MQ4 2023: $271.4MQ1 2024: $197.6MQ2 2024: $142.9MQ3 2024: $79.9MQ4 2024: $90.5MQ1 2025: $50.0MQ2 2025: $40.4MQ3 2025: $84.6MQ4 2025: $81.1MQ1 2026: $120.8MQ2 2026: $98.5M
Institutions holding CHRS and their total value by quarter
QuarterHoldersValue
Q2 2026146$98.5M
Q1 2026158$120.8M
Q4 2025128$81.1M
Q3 2025114$84.6M
Q2 2025112$40.4M
Q1 2025117$50.0M
Q4 2024124$90.5M
Q3 2024128$79.9M
Q2 2024135$142.9M
Q1 2024137$197.6M
Q4 2023156$271.4M
Q3 2023169$347.6M
Q2 2023161$371.1M
Q1 2023163$536.5M
Q4 2022161$622.7M
Q3 2022174$743.4M
Q2 2022176$572.0M
Q1 2022184$980.7M
Q4 2021201$1.23B
Q3 2021188$1.22B
Q2 2021188$1.08B
Q1 2021205$1.17B

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Coherus Oncology, Inc.; share changes are against Q2 2024.

Institutions holding CHRS in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Bank of America Corp661,680$688.1K0.00%+386,585+140.5%Added
Two Sigma Investments, LP682,380$709.7K0.00%−151,861−18.2%Reduced
Peregrine Capital Management LLC734,877$764.3K0.02%−277,758−27.4%Reduced
Disciplined Growth Investors Inc766,308$797.0K0.02%−490,781−39.0%Reduced
Clearline Capital LP784,449$815.8K0.07%00.0%Unchanged
Hudson Bay Capital Management LP785,000$816.4K0.01%00.0%Unchanged
Millennium Management LLC797,511$829.4K0.00%+181,483+29.5%Added
Morgan Stanley826,977$860.1K0.00%−729,873−46.9%Reduced
Lazard Asset Management LLC883,729$919.0K0.00%+252,982+40.1%Added
Northern Trust Corp896,735$932.6K0.00%−17,011−1.9%Reduced
Macquarie Group Ltd899,999$936.0K0.00%00.0%Unchanged
Los Angeles Capital Management LLC930,132$967.3K0.00%+720,672+344.1%Added
Tejara Capital Ltd958,364$996.7K0.48%−72,022−7.0%Reduced
Charles Schwab Investment Management Inc964,327$1.00M0.00%+116,217+13.7%Added
AQR Capital Management LLC1,519,711$1.58M0.00%+799,712+111.1%Added
C WorldWide Group Holding A/S1,928,464$2.01M0.02%00.0%Unchanged
CM Management, LLC2,000,000$2.08M1.66%+900,000+81.8%Added
State Street Corp2,026,332$2.11M0.00%+13,579+0.7%Added
Goldman Sachs Group Inc2,077,643$2.16M0.00%−82,388−3.8%Reduced
Tang Capital Management LLC2,350,000$2.44M0.17%+1,300,000+123.8%Added
Barclays PLC2,466,305$2.56M0.00%+275,784+12.6%Added
Geode Capital Management, LLC2,565,145$2.67M0.00%+182,914+7.7%Added
Citadel Advisors LLC2,857,208$2.97M0.00%+13,760+0.5%Added
Kohlberg Kravis Roberts & Co. L.P.3,036,076$3.12M0.04%00.0%Unchanged
Rubric Capital Management LP10,400,000$10.8M0.18%00.0%Unchanged
Vanguard Group Inc11,310,682$11.8M0.00%+708,293+6.7%Added
BlackRock, Inc.11,951,953$12.4M0.00%+11,951,953New
International Assets Investment Management, LLC47,599––+5,381+12.7%Added
Temasek Holdings (Private) Ltd0$00.00%−5,818,802−100.0%Sold out
BIT Capital GmbH0$00.00%−838,947−100.0%Sold out
Norges Bank0$00.00%−491,500−100.0%Sold out
Marshall Wace, LLP0$00.00%−420,326−100.0%Sold out
Wellington Management Group LLP0$00.00%−369,702−100.0%Sold out
Woodline Partners LP0$00.00%−322,680−100.0%Sold out
Pennant Investors, LP0$00.00%−168,100−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−72,955−100.0%Sold out
MetLife Investment Management0$00.00%−62,706−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−46,021−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−44,645−100.0%Sold out
Savant Capital, LLC0$00.00%−32,883−100.0%Sold out
Knights of Columbus Asset Advisors LLC0$00.00%−30,922−100.0%Sold out
Walleye Capital LLC0$00.00%−28,137−100.0%Sold out
Tiaa Trust, National Association0$00.00%−27,261−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−19,556−100.0%Sold out
Principal Financial Group Inc0$00.00%−17,372−100.0%Sold out
ELCO Management Co., LLC0$00.00%−12,716−100.0%Sold out
Princeton Global Asset Management LLC0$00.00%−10,474−100.0%Sold out
Squarepoint Ops LLC0$00.00%−10,214−100.0%Sold out
nVerses Capital, LLC0$00.00%−4,500−100.0%Sold out
Main Street Group, LTD0$00.00%−200−100.0%Sold out
BlackRock Inc.––––Not filed
Susquehanna Fundamental Investments, LLC––––Not filed